Lobbying client · LD-2 disclosures
Molecular Testing Labs on Behalf of Ascendant Strategic Partners
Washington
4 filings from 2 registrants · 2022 · latest filed Aug 4, 2023
Reported on its behalf
$0
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$0
none reported
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
What they lobby on
Issue areas declared on the filings, ranked by how many filings name each one.
Health Issues
HCR
3 filings
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
Bills named in the filings
Every bill reference extracted from the filings' activity descriptions.
- H.R. 4128 117th CongressVALID Act of 20214 filingsthrough 2022
- S. 2209 117th CongressVALID Act of 20213 filingsthrough 2022
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
Who did the lobbying
Every lobbyist named on this client's filings.
- Andrew Vogt Andrew Vogt Strategies LLCCovered position: Health Professional Staff Member, Senate Health, Education, Labor, and Pensions Committee; Legislative Assistant, Senator Mark Kirk4 filingsthrough 2022
- Andrew Vogt Hart Health StrategiesCovered position: Office of Senator Mark Kirk Senate HELP Committee1 filingthrough 2022
Covered positions · 2 of 2 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: molecular-testing-labs-on-behalf-of-ascendant-strategic-partners.